NASDAQ: NRXPNrx Pharmaceuticals Inc Stock Ownership - Who owns Nrx Pharmaceuticals?
Insider buying vs selling
Have Nrx Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Chaim Hurvitz | Director | 2023-08-30 | 70,000 | $0.29 | $20.09kBuy |
| Aaron Gorovitz | Director | 2023-08-30 | 35,000 | $0.32 | $11.20kBuy |
| Jonathan C. Javitt | Chief Scientist | 2023-08-23 | 100,000 | $0.33 | $33.00kBuy |
| Jonathan C. Javitt | Chief Scientist | 2023-08-22 | 200,000 | $0.32 | $64.40kBuy |
| Stephen H. Willard | CHIEF EXECUTIVE OFFICER | 2022-12-16 | 50,000 | $1.17 | $58.50kBuy |
| Voorhees Seth Van | CHIEF FINANCIAL OFFICER | 2022-12-16 | 30,000 | $1.10 | $33.00kBuy |
| Jonathan C. Javitt | Director | 2022-12-07 | 400,000 | $1.00 | $400.00kSell |
| Daniel C. Javitt | 10% Owner | 2022-11-30 | 8,441 | $1.51 | $12.70kSell |
| Daniel C. Javitt | 10% Owner | 2022-11-29 | 13,730 | $1.50 | $20.65kSell |
| Patrick John Flynn | Director | 2022-11-28 | 1,750 | $1.25 | $2.19kBuy |
NRXP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NRXP insiders and whales buy or sell their stock.
NRXP Shareholders
What type of owners hold Nrx Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Jonathan C. Javitt | 35.78% | 29,236,658 | $7.48M | Insider |
| Daniel C. Javitt | 28.89% | 23,606,657 | $6.04M | Insider |
| Armistice Capital LLC | 6.90% | 5,636,000 | $1.44M | Institution |
| Chaim Hurvitz | 2.97% | 2,423,236 | $620.35k | Insider |
| Brac Lending Group LLC | 2.73% | 2,228,435 | $570.48k | Insider |
| Vanguard Group Inc | 1.81% | 1,478,153 | $378.41k | Institution |
| Polar Asset Management Partners Inc | 1.23% | 1,005,536 | $257.42k | Insider |
| Sabby Management LLC | 0.86% | 699,731 | $179.13k | Institution |
| Big Rock Partners Sponsor LLC | 0.64% | 519,315 | $132.94k | Insider |
| Cvi Holdings LLC | 0.59% | 483,569 | $123.79k | Institution |
NRXP vs Biotech Stocks
Nrx Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.